Cost-Utility Analysis Of Fidaxomicin Compared To Vancomycin In The Management Of Severe Clostridium Difficile Infection In Poland

Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.828
https://www.valueinhealthjournal.com/article/S1098-3015(14)02758-2/fulltext
Section Title : Disease-Specific Studies
Section Order : 251
First Page : A368
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02758-2&doi=10.1016/j.jval.2014.08.828
HEOR Topics :
Tags :
Regions :